Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription 02.11.2026 1 Ann Nucl Med 1 Appl Radiat Isot 1 Circ Cardiovasc Imaging 1 Hum Brain Mapp 1 J Cereb Blood Flow Metab 1 J Nucl Cardiol 14 J Nucl Med 6 Nucl Med Commun 1 Nuklearmedizin 3 PLoS One 4 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Nucl Med

1. AKATSUKA T, Ogawa K
   Deep learning-based simultaneous separation of overlapping projection data and attenuation and scatter correction for multi-pinhole SPECT.
   Ann Nucl Med. 2026 Oct 24. doi: 10.1007/s12149-026-02307.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

2. RAED MD, Muka PK, Franze DL, Martins AAF, et al
   A Monte Carlo-based evaluation of sensitivity, count rate performance, and spatial resolution in circular vs. elliptical PET scanner geometries.
   Appl Radiat Isot. 2026;239:113018.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

3. HIJAZI W, Zhou J, Miller RJH, Ramirez G, et al
   Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry.
   Circ Cardiovasc Imaging. 2026 Oct 28:e020062.
   PubMed         Abstract available
   
   

   
   Hum Brain Mapp

4. CANNA A, De Rosa AP, Nicolai E, Salvatore E, et al
   Association Between Gray Matter Microstructure and Glucose Metabolism in Older Adults With Cognitive Decline: A Multimodal Imaging Study.
   Hum Brain Mapp. 2026;47:e70661.
   PubMed         Abstract available
   
   

   
   J Cereb Blood Flow Metab

5. ROCHA A, Machado LS, Soares C, L Ferreira PC, et al
   EXPRESS: Longitudinal FDG-PET reveals early hypermetabolism associated with astrocyte changes in TgF344-AD rats.
   J Cereb Blood Flow Metab. 2026 Oct 28:271678X261504653.
   PubMed         Abstract available
   
   

   
   J Nucl Cardiol

6. BHAMBHVANI GK, Hage FG, Bhambhvani P
   Superiority of SPECT/CT over SPECT alone for Cardiac Amyloid Radionuclide Imaging.
   J Nucl Cardiol. 2026 Oct 29:103008. doi: 10.1016/j.nuclcard.2026.103008.
   PubMed        
   
   

   
   J Nucl Med

7. ZHANG Z, Liu Y, Zhao X
   Reply to "Should Molecular Subtype Influence the Interpretation of Serial (68)Ga-HER2 PET/CT During Neoadjuvant Therapy?".
   J Nucl Med. 2026 Oct 29:jnumed.126.273736. doi: 10.2967/jnumed.126.273736.
   PubMed        
   
   
8. SONNI I, Mohammadigoldar Z, Furey G, Kimura K, et al
   Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study.
   J Nucl Med. 2026 Oct 29:jnumed.126.273367. doi: 10.2967/jnumed.126.273367.
   PubMed         Abstract available
   
   
9. CALAIS J
   Reply to "Beyond Prostate-Specific Antigen Response: Could (18)F-FDG PET Refine Patient Selection for Rechallenge with [(177)Lu]Lu-PSMA-617?".
   J Nucl Med. 2026 Oct 29:jnumed.126.274063. doi: 10.2967/jnumed.126.274063.
   PubMed        
   
   
10. SEBAN RD, Buvat I, Fouque J, Bidard FC, et al
    Toward a Theranostic Role for Trop2 Immuno-PET.
    J Nucl Med. 2026 Oct 29:jnumed.126.273479. doi: 10.2967/jnumed.126.273479.
    PubMed        
    
    
11. CHABAN A, Yakushev I
    TBR(max) After FDA Approval of [(18)F]FET PET: 1 Name, 2 Measurements.
    J Nucl Med. 2026 Oct 29:jnumed.126.274022. doi: 10.2967/jnumed.126.274022.
    PubMed        
    
    
12. WATANABE M, Jentzen W, Herrmann K, Kersting D, et al
    Predicting [(90)Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [(68)Ga]Ga-FAPI-46 PET/CT Imaging.
    J Nucl Med. 2026 Oct 29:jnumed.126.273258. doi: 10.2967/jnumed.126.273258.
    PubMed         Abstract available
    
    
13. MUELLER J, Zhao T, Jakobsson V, Shiyam Sundar LK, et al
    Botulinum Toxin Plus Transdermal Scopolamine Reduces Salivary Gland Uptake in Patients Undergoing Tandem Radiopharmaceutical Therapy with [(225)Ac]Ac- and [(177)Lu]Lu-PSMA Radioligands.
    J Nucl Med. 2026 Oct 29:jnumed.125.271922. doi: 10.2967/jnumed.125.271922.
    PubMed         Abstract available
    
    
14. CINAR A
    Beyond Prostate-Specific Antigen Response: Could (18)F-FDG PET Refine Patient Selection for Rechallenge with [(177)Lu]Lu-PSMA-617?
    J Nucl Med. 2026 Oct 29:jnumed.126.273292. doi: 10.2967/jnumed.126.273292.
    PubMed        
    
    
15. ALTUNDAG K
    Should Molecular Subtype Influence the Interpretation of Serial (68)Ga-HER2 PET/CT During Neoadjuvant Therapy?
    J Nucl Med. 2026 Oct 29:jnumed.126.273659. doi: 10.2967/jnumed.126.273659.
    PubMed        
    
    
16. BORM FJ, Smit J, Gerards NR, Wiegers SE, et al
    (18)F-BMS-986192 PET to Predict Durable Response to Nivolumab in NSCLC: A Novel Approach Beyond PD-L1 Immunohistochemistry.
    J Nucl Med. 2026 Oct 29:jnumed.126.272588. doi: 10.2967/jnumed.126.272588.
    PubMed         Abstract available
    
    
17. SZIDONYA L, Obrzut S, Lim JY, Latour E, et al
    Role of [(18)F]F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and Negative PSMA PET Results: A Single-Center Study.
    J Nucl Med. 2026 Oct 29:jnumed.126.272834. doi: 10.2967/jnumed.126.272834.
    PubMed         Abstract available
    
    
18. ESMAEILZADEH ASL S, Hoberuck S, Sonnenfeld A, Stange T, et al
    Impact of PSMA PET/CT Staging on Long-Term Outcomes in Patients with Clinically Localized Prostate Cancer: Results of a Large Single-Center Cohort.
    J Nucl Med. 2026 Oct 29:jnumed.126.273261. doi: 10.2967/jnumed.126.273261.
    PubMed         Abstract available
    
    
19. YADAV S, Khan S, Moradi Tuchayi A, Moradpour M, et al
    Patterns of Progression on Posttreatment Imaging During [(177)Lu]Lu-PSMA Radiopharmaceutical Therapy.
    J Nucl Med. 2026 Oct 29:jnumed.126.272228. doi: 10.2967/jnumed.126.272228.
    PubMed         Abstract available
    
    
20. WEI W
    Reply to "Toward a Theranostic Role for Trop2 Immuno-PET".
    J Nucl Med. 2026 Oct 29:jnumed.126.274060. doi: 10.2967/jnumed.126.274060.
    PubMed        
    
    

    
    Nucl Med Commun

21. SHIH PF
    From chatbot to clinical copilot: the role of generative artificial intelligence in nuclear medicine reporting and data extraction.
    Nucl Med Commun. 2026 Oct 22. doi: 10.1097/MNM.0000000000002254.
    PubMed         Abstract available
    
    
22. EMERSON RP, Parida GK, Agrawal K
    Diagnostic accuracy of carbonic anhydrase IX-targeted PET/CT for detection of clear cell renal cell carcinoma in patients with renal masses: a systematic review and meta-analysis of diagnostic test accuracy studies.
    Nucl Med Commun. 2026 Oct 23. doi: 10.1097/MNM.0000000000002257.
    PubMed         Abstract available
    
    
23. BAYQUEN DDA, Aguiar A, Morris K, McElligott K, et al
    'A tracer is still a drug': a potential medicines-recording blind spot in nuclear medicine.
    Nucl Med Commun. 2026 Oct 26. doi: 10.1097/MNM.0000000000002251.
    PubMed        
    
    
24. MEHTIYEV M, Kos FT
    Preoperative 18F-fluorodeoxyglucose PET/computed tomography maximum standardized uptake value is independently associated with overall survival in surgically resected undifferentiated pleomorphic sarcoma.
    Nucl Med Commun. 2026 Oct 26. doi: 10.1097/MNM.0000000000002255.
    PubMed         Abstract available
    
    
25. GULBAHAR ATES S, Bozyigit MN, Aydos U, Atay LO, et al
    18F-FDG PET/MRI-based liver and bone marrow organomics combined with systemic inflammatory response for predicting pathological complete response after neoadjuvant therapy in breast cancer.
    Nucl Med Commun. 2026 Oct 28. doi: 10.1097/MNM.0000000000002266.
    PubMed         Abstract available
    
    
26. JAIN A, Al Sukaiti R, Kheruka S, Usmani S, et al
    Technetium-99m macroaggregated albumin scan before yttrium-90 radioembolization: what to look for and why it matters.
    Nucl Med Commun. 2026 Oct 30. doi: 10.1097/MNM.0000000000002261.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

27. KAUFMANN J, Kattinger C, Blumel S, Bartel C, et al
    Patient Acceptance of Semi-Inpatient Radioligand Therapy: Insights from a Prospective Survey in Nuclear Medicine.
    Nuklearmedizin. 2026 Oct 26. doi: 10.1055/a-2966-9616.
    PubMed         Abstract available
    
    

    
    PLoS One

28. KAOLAWANICH Y, Meechuen M, Laohabut I, Ruengchaisiwawaith T, et al
    Association between coronary artery calcium score and myocardial ischemia assessed by stress perfusion cardiac magnetic resonance imaging.
    PLoS One. 2026;21:e0361659.
    PubMed         Abstract available
    
    
29. LIANG C, Tucker TE, Coronel ADL, Nguyen EHN, et al
    Imaging [18F]FDG PET/CT pilot study of nicotinic acetylcholinergic receptor alpha2 knock-out mice and alpha2 hypersensitive mice compared to control mice: Male-female differences and nicotine effects.
    PLoS One. 2026;21:e0346469.
    PubMed         Abstract available
    
    
30. VARTIAINEN N, Hartikainen S, Rissanen AE, Kariniemi E, et al
    Atrial fibrillation is independently associated with impaired myocardial perfusion.
    PLoS One. 2026;21:e0361402.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

31. SADEGHPOUR S, Mirshahvalad SA, Askari E, Doostparast A, et al
    Fibroblast activation protein-targeted PET uptake across various histopathological and molecular subtypes of breast cancer: a systematic review and meta-analysis.
    Semin Nucl Med. 2026 Oct 29:S0001-2998(26)00193.
    PubMed         Abstract available
    
    
32. VAN SCHAIK L, Huisman SA, Appelman-Dijkstra NM, de Geus-Oei LF, et al
    Diagnostic accuracy and clinical value of quantitative Na[(18)F]F PET/CT parameters to monitor therapeutic response in patients with benign metabolic bone diseases: A systematic review.
    Semin Nucl Med. 2026 Oct 28:S0001-2998(26)00188.
    PubMed         Abstract available
    
    
33. BECKER S, Tually P, Currie GM
    Companion animal nuclear medicine: A translational evidence map for dogs and cats.
    Semin Nucl Med. 2026 Oct 28:S0001-2998(26)00191.
    PubMed         Abstract available
    
    
34. IMPERIALE A, Mouissi I, Huon M, Taieb D, et al
    Normal variants, pitfalls, and interpretation challenges of somatostatin receptor PET.
    Semin Nucl Med. 2026 Oct 24:S0001-2998(26)00189.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum